Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies

References

• Halpern MT , Luce BR , Brown RE , Geneste B . Health and economic outcomes modeling practices: a suggested framework. Value Health 1998;1(2):131-47
   PubMedGoogle Scholar
• Stahl JE . Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics 2008;26(2):131-48
   PubMed Web of Science ®Google Scholar
• Barton P , Bryan S , Robinson S . Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004;9(2):110-18
   PubMedGoogle Scholar
• Brennan A , Chick SE , Davies R . A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006;15(12):1295-310
   PubMed Web of Science ®Google Scholar
• Tsoi B , Jegathisawaran J , Tarride JE , et al. Systematic narrative review of decision frameworks to select appropriate modelling approaches for economic evaluations. BMC Research Notes; 2015; manuscript submitted
   Google Scholar
• Kim SY , Goldie SJ . Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. Pharmacoeconomics 2008;26(3):191-215
   PubMed Web of Science ®Google Scholar
• Eddy DM , Hollingworth W , Caro JJ , et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7. Value Health 2012;15(6):843-50
   PubMed Web of Science ®Google Scholar
• Meadows D , Robinson J . The electronic oracle. Computer models and social decisions. John Wiley & Sons; Chichester, UK; 1985
   Google Scholar
• Standfield L , Comans T , Scuffham P . Markov modeling and discrete event simulation in health care: a systematic comparison. Int J Technol Assess Health Care 2014;30(02):165-72
   PubMedGoogle Scholar
• Lugner AK , Mylius SD , Wallinga J . Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Health Econ 2010;19(5):518-31
   PubMed Web of Science ®Google Scholar
• Simpson KN , Strassburger A , Jones WJ , et al. Comparison of Markov model and discrete-event simulation techniques for HIV. Pharmacoeconomics 2009;27(2):159-65
   PubMed Web of Science ®Google Scholar
• Pradas-Velasco R , Antonanzas-Villar F , Martinez-Zarate MP . Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination. Pharmacoeconomics 2008;26(1):45-56
   PubMed Web of Science ®Google Scholar
• Kuehne FC , Chancellor J , Mollon P . Microsimulation or cohort modelling? A comparative case study in HIV infection. iHEA 2007 6th world congress: explorations in health economics paper. 2007. Available from: http://ssrn.com/abstract=994349
   Google Scholar
• Welte R , Postma M , Leidl R , Kretzschmar M . Costs and effects of Chlamydial screening: dynamics versus static modelling. Sex Transm Dis 2005;32(8):474-83
   PubMed Web of Science ®Google Scholar
• Jahn B , Rochau U , Arvandi M , et al. Lessons learned from a cross-validation between a discrete-event simulation model and a Markov model for personalized breast cancer treatment. Value in Health Conference: ISPOR 15th Annual European Congress. Berlin, Germany. Conference Start: 20121103 Conference End: 20121107. Conference Publication:(var.pagings), A283 2012
   Google Scholar
• Karnon J . Alternative decision modelling techniques for the evaluation of health care technologies: markov processes versus discrete event simulation. Health Econ 2003;12(10):837-48
   PubMed Web of Science ®Google Scholar
• Chrosny W , Stevenson M , Munzer A . Comparison of Markov and discrete event simulation modeling techniques with application to cost effectiveness analysis. Value Health 2013;16(7):A587
   Web of Science ®Google Scholar
• Edmunds WJ , Medley GF , Nokes DJ . Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999;18(23):3263-82
   PubMed Web of Science ®Google Scholar
• Jit M , Brisson M . Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics 2011;29(5):371-86
   PubMed Web of Science ®Google Scholar
• Armstrong GL , Billah K , Rein DB , et al. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics 2007;119(1):e22-9
   PubMed Web of Science ®Google Scholar
• Brisson M , Edmunds WJ . Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Med Decis Making 2006;26(5):434-46
   PubMed Web of Science ®Google Scholar
• Kim SY , Goldie SJ , Salomon JA . Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam. Med Decis Making 2010;30(5):E1-E28
   PubMed Web of Science ®Google Scholar
• Trotter CL , Edmunds WJ . Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making 2006;26(1):38-47
   PubMed Web of Science ®Google Scholar
• Jahn B , Pfeiffer KP , Theurl E , et al. Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents. Med Decis Making 2010;30(1):16-28
   PubMed Web of Science ®Google Scholar
• Eddy DM , Hollingworth W , Caro JJ , et al. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force–7. Value Health 2012;15(6):843-50
   PubMed Web of Science ®Google Scholar
• Palmer AJ , Clarke P , Gray A , et al. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood Challenge meeting. Value Health 2013;16(4):670-85
   PubMed Web of Science ®Google Scholar